CD8A and neoplasm: Serotonin (5-HT)-mediated serotonylation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) drives the metabolic shift to glycolysis in CD8+ T cells, enhancing anti-tumor immunity.